Abstract
Rreal-World Results from Anti-CD19 CAR-T Cell Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Spain and Comparison with Previous Standard of Care: A Geltamo/Geth Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have